The EU supports pediatric research through funding programs such as Horizon Europe, which is the EU’s key funding program for research and innovation. This program provides grants for projects that aim to improve pediatric care, develop new treatments, and address rare pediatric diseases. Additionally, EU agencies like the European Medicines Agency (EMA) play a crucial role in the regulation and approval of pediatric medicines, ensuring their safety and efficacy.
